The Pharmacodynamic and Clinical Activities of Daflon 500 mg: Therapeutic Effect of Micronization

Abstract

Objective:

To review the pharmacodynamic and clinical activities of Daflon 500 mg.

Data selection:

Choice of relevant publications in the literature.

Conclusion:

The pharmacological activities of Daflon 500 mg on capillary hyperpermeability, inflammatory mediators and lymphatic drainage can explain its therapeutic efficacy in the treatment of chronic venous insufficiency.

Keywords

Chronic venous insufficiency Flavonoid Hyperpermeability Inflammation

Get full access to this article

View all access options for this article.

References

Amiel

, Barbe

Etude de de'lai et de la durée d'action du Daflon 500 mg. J Int Med 1987;85 (suppl):19-21.

Tsouderos

Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg. Inter Angio 1989;8 (Suppl 4):53-9.

Cospite

Double-blind study of pharmacodynamic and clinical activities of Daflon 500 mg in venous insufficiency. Advantages of the new micronized form. Inter Angio 1989;8 (Suppl 4):61-5.

Labrid

Poprietes pharmacologique de Daflon 500 mg. J Int Med 1987;85 (suppl):30-5.

Damon

. Effect of chronic treatment with a purified flavonoid fraction on inflammatory granuloma in the rat. Study of prostaglandin E2 and F2-alpha and thromboxane B2 release and histological changes. Arzneim Forsch/Drug Res 1987;37(II) 10:1149-53.

Duhault

Mécanisme d'action de Daflon 500 mg sur le tonus veineux. Artères Veines 1992;11(4):217-8.

Di Perri

, Auteri

Action of S 5682 on the complement system. In vivo and in vitro studies. Inter Ango 1988; (Suppl 2):11-15.

Cotonat

, Cotonat

MD.

Lymphagogue and pulsatile activities of Daflon 500 mg on canine thoracic lymph duct. Inter Angio 1989;8(Suppl 4):15-8.